MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $9 million in its first quarter.

On a per-share basis, the Monmouth Junction, New Jersey-based company said it had a loss of 21 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

The blood purification therapy company posted revenue of $8.7 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $9.7 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO